article thumbnail

Eli Lilly to Buy Gene Therapy Firm Verve in $1 Billion Deal to Develop Heart Drug

Physician's Weekly

WEDNESDAY, June 18, 2025 (HealthDay News) — Drugmaker Eli Lilly plans to buy Verve Therapeutics , a gene-editing startup, for about $1 billion upfront. Verve is developing a new class of gene-editing drugs that could be given just once to treat chronic conditions. The deal, announced June 17, includes a cash offer of $10.50

article thumbnail

Navigating the Quademic: Clinical Differentiation of Influenza, RSV, COVID-19, and Norovirus in Pediatric Emergency Care

PEMBlog

Diagnostic Costs : Influenza rapid diagnostic tests: $100-$200 Risk Stratification : Young children (<5 years), particularly those <2 years, and children with chronic conditions such as asthma or immunosuppression, are at higher risk for severe outcomes. Treasure Island (FL): StatPearls Publishing; 2025 Jan-.Available

Clinic 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Deprescribing Super Special III: Constance Fung, Emily McDonald, Amy Linsky, and Michelle Odden

GeriPal

In our third segment, we explore Amy Linskys study that examined the effect of patient-directed educational materials on clinician deprescribing of potentially low-benefit or high-risk medications, such as proton pump inhibitors, high-dose gabapentin, or risky diabetes medications. So insulin, which is the injections, and then sulfonylurea.

article thumbnail

Transgender Health, Aging, and Advocacy: A Podcast with Noelle Marie Javier and Jace Flatt

GeriPal

What does that mean for dealing with chronic conditions and syndromes of aging, their health, does it have an impact? But there have been some studies showing higher rates of chronic conditions. ABIM MOC credit will be offered to subscribers in November, 2025. What do we know about that? Noelle Marie 27:00 A lot.

article thumbnail

When to Go to Urgent Care for a Sore Throat: How Can Urgent Care Help?

Doctor On Demand

In fact, most sore throat symptoms resolve in three days for 60-70% of patients, according to March 2025 UpToDate, an evidence-based clinical decision support system used by healthcare professionals. due to chemotherapy, diabetes, or autoimmune disease)? chemotherapy or steroids). Do you have a weak immune system (e.g.,

ER 52